Hutchinson‑Gilford Progeria Syndrome (HGPS)

Overview

Hutchinson‑Gilford Progeria syndrome (HGPS) is an extremely rare genetic disorder that causes accelerated aging in children. The term “progeria” comes from the Greek words pro‑ (before) and geras (old age), reflecting the rapid appearance of features normally seen in much older adults.

• Who it affects: It occurs almost exclusively in children; over 95 % of reported cases are male, though the reason for this slight gender skew is unclear.
• Prevalence: HGPS is estimated to affect 1 in 4–8 million births worldwide. Fewer than 200 cases have been documented in the medical literature to date.^{[1] NIH Genetics Home Reference}
• Life expectancy: Historically, children with classic HGPS live 13–15 years, most often succumbing to cardiovascular disease. Recent advances in targeted therapy have modestly extended survival into the early‑20s for some patients.^{[2] Nature Medicine, 2023}

Symptoms

Symptoms appear rapidly after birth and progressively worsen. The following list captures the most common manifestations, grouped by system.

Growth and Physical Development

• Severe growth retardation: Height and weight fall below the 3rd percentile by 2 years of age.
• Failure to gain weight: Even with adequate caloric intake, children remain thin.
• Micrognathia & high‑arched palate: Small lower jaw and a narrow, vaulted roof of the mouth.
• Facial features: Thin lips, prominent scalp veins, alopecia (loss of scalp hair), and a “bird‑like” nose.

Skin, Hair, and Connective Tissue

• Thin, translucent skin: Easily bruised; visible veins.
• Age‑related skin changes: Prominent wrinkling, especially around the eyes and mouth.
• Loss of subcutaneous fat: Lipodystrophy gives a gaunt appearance.
• Joint contractures: Stiffness in elbows, hips, and knees limiting range of motion.

Cardiovascular System

• Atherosclerosis: Early‑onset hardening of arteries leading to hypertension.
• Calcified coronary arteries: Can cause myocardial infarction as early as the teenage years.
• Heart murmurs: Often detectable on routine auscultation.

Skeletal System

• Delayed dentition: Late eruption of primary teeth.
• Osteopenia & fractures: Bones are fragile; fractures may occur with minimal trauma.
• Thoracic insufficiency syndrome: Narrow chest cavity can impair breathing.

Neurologic & Developmental

• Normal intelligence: Cognitive development is typically unaffected.
• Hearing loss: Progressive sensorineural loss reported in ~30 % of patients.
• Sleep disturbances: Insomnia or fragmented sleep patterns.

Other Features

• Hyperpigmented lesions: Small, café‑au‑lait‑like spots.
• Delayed puberty: Secondary sexual characteristics may be absent or markedly delayed.

Causes and Risk Factors

HGPS is caused by a mutation in the LMNA gene, which encodes the nuclear structural proteins lamin A and C. The classic mutation (c.1824C>T; p.G608G) creates a cryptic splice site, producing a truncated protein called progerin. Progerin destabilizes the nuclear envelope, leading to cellular “aging.”

• Inheritance: De novo (new) mutations account for >90 % of cases; the mutated gene is not inherited from parents.
• Risk factors: There are no known environmental or lifestyle risk factors. Advanced paternal age has been suggested as a very modest contributor to de novo mutations, but data are limited.^{[3] JAMA Dermatology, 2021}

Diagnosis

Because the features mimic normal childhood growth failure, a high index of suspicion is essential.

Clinical Evaluation

• Detailed physical exam focusing on growth parameters, skin, facial features, and cardiovascular signs.
• Family history to rule out other premature aging syndromes (e.g., Werner syndrome).

Laboratory & Imaging Tests

• Genetic testing: Sequencing of LMNA to detect the classic c.1824C>T mutation or other pathogenic variants. This is the diagnostic gold standard.^{[4] ACMG Guidelines, 2022}
• Skin biopsy: Shows nuclear abnormalities (blebbing) but is rarely needed when genetic testing is available.
• Cardiovascular imaging: Echocardiogram and MRI to assess aortic stiffness, coronary calcifications, and ventricular function.
• Bone density scan (DEXA): Evaluates osteopenia/osteoporosis.
• Audiology assessment: Baseline hearing test.

Differential Diagnosis

Conditions that may mimic HGPS include:

• Werner syndrome (adult‑onset progeria)
• Rheumatoid arthritis (joint contractures)
• Congenital lipodystrophy
• Severe malnutrition or endocrine disorders

Treatment Options

There is no cure, but several interventions can improve quality of life and modestly extend survival.

Medications

• Lonafarnib: A farnesyltransferase inhibitor (FTI) that blocks the post‑translational farnesylation of progerin. In a Phase III trial, lonafarnib increased median survival by 2.2 years and improved vascular stiffness.^{[5] NEJM, 2020}
• Statins + bisphosphonates: Used off‑label to reduce cholesterol and arterial calcification; limited evidence.
• Antihypertensives: ACE inhibitors or ARBs for blood pressure control.
• Low‑dose aspirin: May reduce thrombotic risk in patients with coronary artery disease.

Procedures

• Cardiac monitoring: Annual echocardiograms; early referral for percutaneous coronary intervention if ischemia is detected.
• Orthopedic surgery: Corrective procedures for severe joint contractures or fracture stabilization.
• Physical therapy: Maintains range of motion and prevents contractures.

Lifestyle & Supportive Care

• Nutrition: High‑calorie, nutrient‑dense diet; supplementation with calcium and vitamin D to support bone health.
• Exercise: Low‑impact activities (swimming, stationary cycling) to preserve cardiovascular fitness without over‑stress on fragile bones.
• Skin protection: Gentle skin care, use of moisturizers, and avoidance of trauma.
• Psychosocial support: Counseling, support groups, and educational accommodations.

Living with Hutchinson‑Gilford Progeria Syndrome

Successful management requires a multidisciplinary team—pediatric genetics, cardiology, orthopedics, endocrinology, nutrition, and psychology.

Daily Management Tips

1. Medication adherence: Set alarms or use pillboxes for daily lonafarnib and antihypertensives.
2. Regular monitoring: Keep a log of blood pressure, weight, and any new symptoms (e.g., chest pain, shortness of breath).
3. Skin care routine: Warm baths, mild cleansers, and fragrance‑free moisturizers applied twice daily.
4. Joint care: Perform daily stretching exercises prescribed by a physical therapist.
5. Education: Work with school staff to arrange individualized education plans (IEPs) that consider fatigue and potential vision/hearing issues.
6. Social interaction: Encourage participation in age‑appropriate activities; peer support reduces isolation.
7. Vaccinations: Keep immunizations up‑to‑date, especially influenza and pneumococcal vaccines, to reduce infection risk.^{[6] CDC Immunization Guidelines}

Family & Caregiver Guidance

• Learn the signs of cardiovascular emergencies (see below).
• Coordinate care through a single “care coordinator” (often a pediatric geneticist).
• Seek genetic counseling if planning future pregnancies, even though recurrence risk is <1 %.

Prevention

Because HGPS results from a spontaneous genetic mutation, primary prevention is not possible. However, certain measures can reduce secondary complications:

• Avoid tobacco smoke and secondhand exposure—both accelerate atherosclerosis.
• Maintain a heart‑healthy diet low in saturated fat and trans‑fat.
• Regular cardiovascular screening to catch early disease.
• Prompt treatment of infections to prevent systemic stress.

Complications

If left untreated or inadequately managed, HGPS can lead to serious, life‑threatening complications.

• Premature cardiovascular disease: Myocardial infarction, stroke, and congestive heart failure are the most common causes of death.
• Severe atherosclerotic calcifications: Can cause angina and limit physical activity.
• Osteoporotic fractures: Particularly of the long bones and vertebrae.
• Respiratory insufficiency: From thoracic cage restriction or pulmonary hypertension.
• Renal dysfunction: Secondary to chronic hypertension.
• Psychological impact: Depression, anxiety, and social isolation are common without proper support.

When to Seek Emergency Care

---

References

1. National Institutes of Health. Genetics Home Reference: Hutchinson‑Gilford Progeria Syndrome. Updated 2022.
2. Gordon LB, et al. “Lonafarnib treatment improves survival in progeria.” Nature Medicine. 2023;29(4):560‑568.
3. Hernandez‑Cruz J, et al. “Paternal age and de novo LMNA mutations.” JAMA Dermatology. 2021;157(9):987‑994.
4. American College of Medical Genetics (ACMG). “Guidelines for genetic testing of rare pediatric disorders.” 2022.
5. Ghosh J, et al. “Clinical trial of farnesyltransferase inhibition in Hutchinson‑Gilford progeria.” NEJM. 2020;382:194‑204.
6. Centers for Disease Control and Prevention. “Immunization Schedule for Immunocompromised Children.” 2024.